Lobbying

Argentum Medical Dba Bravida Medical's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q1 2024; the issues it reports most are Budget/Appropriations and Health Issues.

Argentum Medical Dba Bravida Medical

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

Argentum Medical Dba Bravida Medical lobbying by quarter
Argentum Medical Dba Bravida Medical lobbying by quarter
QuarterAmountReports
Q1 2024$40K1
Q2 2024$40K1
Q3 2024$40K1
Q4 2024$40K1
Q1 2025$40K1
Q2 2025$40K1
Q3 2025$40K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Budget and appropriations$146.7K · 9 reports
  • Health issues$146.7K · 9 reports
  • Defense$66.7K · 5 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Defense, Dept of (DOD)2 reports

Firms it paid

Firm
SL Strategies$400K10 quarters

Former officials lobbying for it

Former position
MARY MOODY JOHNSONU.S. Senate Committee on Health, Education, Labor and PensionsQ2 2026

Lobbying reports

Filed by
08/17for Q2SL Strategies$40K
05/04for Q1SL Strategies$40K
01/20for Q4 2025SL Strategies$40K
25/11/10for Q3 2025SL Strategies$40K
25/07/22for Q2 2025SL Strategies$40K
25/04/21for Q1 2025SL Strategies$40K
25/02/20for Q4 2024SL Strategies$40K
24/10/31for Q3 2024SL Strategies$40K
24/08/22for Q2 2024SL Strategies$40K
24/08/22for Q1 2024SL Strategies$40K
24/07/16for Q1 2024SL StrategiesUnder $5,000